Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Avatrombopag(Doptelet)

Thrombocytopenia in patients with chronic liver disease and chronic immune disorders.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：235
Cabozantinib(Cabometyx)

Cabozantinib has been approved for the treatment of various cancers.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：224
Osimertinib(Tagrisso)

Suitable for locally advanced or metastatic non-small cell lung cancer (NSCLC) patients with EGFRT790M mutation positivity.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：45
Eltrombopag(Revolade)

Treat thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：215
Crizotinib(Xalkori)

Crizotinib is suitable for the treatment of non-small cell lung cancer.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：155
Finerenone(Kerendia)

Finerenone is applicable to chronic kidney disease related to type 2 diabetes.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：216
Mitotane(Lysodren)

Mitotane is used for treatment Adrenal cortex carcinoma.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：200
Cibinqo(Abrocitinib)

Cibinqo can treat atopic dermatitis.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：203
Anamorelin(Adlumiz)

Broad-spectrum antitumor agents【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：190
Adagrasib(Krazati)

‌KRAS G12C mutation in non-small cell lung cancer and colorectal cancer‌【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：210
Brigatinib(Alunbrig)

The treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) patients.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：138
Koselugo(Selumetinib)

Koselugo is suitable for treating children aged 2 years and above with type 1 neurofibromatosis.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：200

home page previous 43 43/102 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：[list:visits]2025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：[list:visits]2026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：[list:visits]2026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in Laos
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】

Recommended：[list:visits]2026-30-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More